Sanofi (SAN1N) Stock Forecast & Price Target
SAN1N Analyst Ratings
Moderate Buy
6Buy6Hold0Sell
Based on 12 analysts giving stock ratings to Sanofi in the past 3 months
SAN1N Stock 12 Month Forecast
Average Price Target
MXN 1,940.91▲(26.63% Upside)Based on 12 Wall Street analysts offering 12 month price targets for Sanofi in the last 3 months. The average price target is MXN 1,940.91 with a high forecast of MXN 2,228.17 and a low forecast of MXN 1,636.35. The average price target represents a 26.63% change from the last price of MXN 1,532.71.
Past 12 Months12 Month ForecastJan2026Oct2026
HighMXN 2.23K
AverageMXN 1.94K
LowMXN 1.64K
Highest Price TargetHighestMXN 2,228.17Average Price TargetMXN 1,940.91Lowest Price TargetLowestMXN 1,636.35
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Trung Huynh | RBC Capital | MXN 1,573.42→MXN 1,678.31 | hold | 9.50%Upside | Reiterated | 11/02/26 | ||
| Justin Smith | Bernstein | MXN 2,228.17 | buy | 45.37%Upside | Reiterated | 10/30/26 | ||
| Michael Leuchten | Jefferies | MXN 2,097.89 | buy | 36.87%Upside | Reiterated | 10/30/26 | ||
| Richard Vosser | J.P. Morgan | MXN 1,992.99 | hold | 30.03%Upside | Reiterated | 10/30/26 | ||
 Unknown AnalystNot Ranked | Leerink Partners | MXN 1,972.01 | buy | 28.66%Upside | Reiterated | 10/19/26 | ||
| Matthew Weston | UBS | MXN 1,636.35 | hold | 6.76%Upside | Reiterated | 10/15/26 | ||
| Sachin Jain | Bank of America Securities | MXN 1,930.06 | hold | 25.92%Upside | Reiterated | 10/08/26 | ||
| Luisa Hector | Berenberg Bank | MXN 2,202.78 | buy | 43.72%Upside | Reiterated | 10/05/26 | ||
| Emmanuel Papadakis | Deutsche Bank | MXN 1,992.99 | buy | 30.03%Upside | Reiterated | 09/29/26 | ||
| Rajesh Kumar | HSBC | MXN 1,992.99→MXN 2,097.89 | buy | 36.87%Upside | Reiterated | 09/10/26 | ||
| James Gordon CFA | Barclays | MXN 1,657.33→MXN 1,741.25 | hold | 13.61%Upside | Reiterated | 09/08/26 | ||
| Sarita Kapila | Morgan Stanley | MXN 1,804.18→MXN 1,720.27 | hold | 12.24%Upside | Reiterated | 08/11/26 | ||
| Elmar Kraus | DZ BANK AG | ― | buy | ― | Reiterated | 07/31/26 | ||
| James Quigley | Goldman Sachs | MXN 1,867.12→MXN 1,762.23 | hold | 14.97%Upside | Reiterated | 07/06/26 | ||
| Nicolas Pauillac | Kepler Capital | MXN 1,783.20 | hold | 16.34%Upside | Reiterated | 04/23/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Trung Huynh | 11/02/26 | MXN 1,573.42→MXN 1,678.31 | hold | 9.50%Upside | Reiterated | RBC Capital | ||
| Justin Smith | 10/30/26 | MXN 2,228.17 | buy | 45.37%Upside | Reiterated | Bernstein | ||
| Michael Leuchten | 10/30/26 | MXN 2,097.89 | buy | 36.87%Upside | Reiterated | Jefferies | ||
| Richard Vosser | 10/30/26 | MXN 1,992.99 | hold | 30.03%Upside | Reiterated | J.P. Morgan | ||
| Unknown AnalystNot Ranked | 10/19/26 | MXN 1,972.01 | buy | 28.66%Upside | Reiterated | Leerink Partners | ||
| Matthew Weston | 10/15/26 | MXN 1,636.35 | hold | 6.76%Upside | Reiterated | UBS | ||
| Sachin Jain | 10/08/26 | MXN 1,930.06 | hold | 25.92%Upside | Reiterated | Bank of America Securities | ||
| Luisa Hector | 10/05/26 | MXN 2,202.78 | buy | 43.72%Upside | Reiterated | Berenberg Bank | ||
| Emmanuel Papadakis | 09/29/26 | MXN 1,992.99 | buy | 30.03%Upside | Reiterated | Deutsche Bank | ||
| Rajesh Kumar | 09/10/26 | MXN 1,992.99→MXN 2,097.89 | buy | 36.87%Upside | Reiterated | HSBC | ||
| James Gordon CFA | 09/08/26 | MXN 1,657.33→MXN 1,741.25 | hold | 13.61%Upside | Reiterated | Barclays | ||
| Sarita Kapila | 08/11/26 | MXN 1,804.18→MXN 1,720.27 | hold | 12.24%Upside | Reiterated | Morgan Stanley | ||
| Elmar Kraus | 07/31/26 | ― | buy | ― | Reiterated | DZ BANK AG | ||
| James Quigley | 07/06/26 | MXN 1,867.12→MXN 1,762.23 | hold | 14.97%Upside | Reiterated | Goldman Sachs | ||
| Nicolas Pauillac | 04/23/26 | MXN 1,783.20 | hold | 16.34%Upside | Reiterated | Kepler Capital |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Sanofi
3 Months
Success Rate15/26 ratings generated profit
58%
Average Return
+1.50%
Copying Luisa Hector's trades and holding each position for 3 Months would result in 57.69% of your transactions generating a profit, with an average return of +1.50% per trade.
1 Year
Success Rate20/35 ratings generated profit
57%
Average Return
+2.56%
Copying David Risinger's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +2.56% per trade.
2 Years
Success Rate15/26 ratings generated profit
58%
Average Return
+6.04%
Copying Florent Cespedes's trades and holding each position for 2 Years would result in 57.69% of your transactions generating a profit, with an average return of +6.04% per trade.
SAN1N Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 10 | 14 | 15 | 16 | 10 |
| Hold | 12 | 13 | 17 | 16 | 15 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 22 | 27 | 32 | 32 | 25 |
In the current month, SAN1N has received 10 Buy Ratings, 15 Hold Ratings, and 0 Sell Ratings. SAN1N average Analyst price target in the past 3 months is 1,940.91.
SAN1N Financial Forecast
HighMXN 44.42
ConsensusMXN 38.50
LowMXN 32.78
SAN1N Earnings Forecast
Next quarter’s earnings estimate for SAN1N is MXN 38.50 with a range of MXN 32.78 to MXN 44.42. The previous quarter’s EPS was MXN 74.73. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 295B
ConsensusMXN 282B
LowMXN 269B
SAN1N Sales Forecast
Next quarter’s sales forecast for SAN1N is MXN 281.64B with a range of MXN 268.83B to MXN 294.83B. The previous quarter’s sales results were ―. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
SAN1N Stock Forecast FAQ
What is MX:SAN1N’s average 12-month price target, according to analysts?
Based on analyst ratings, Sanofi’s 12-month average price target is Mex$1,940.91.
What is MX:SAN1N’s upside potential, based on the analysts’ average price target?
Sanofi has 26.63% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sanofi a Buy, Sell or Hold?
Sanofi has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 6 hold ratings and 0 sell ratings.
What is Sanofi’s share price target?
The average share price target for Sanofi is Mex$1,940.91. This is based on 12 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$2,228.17, and the lowest forecast is Mex$1,636.35. The average share price target represents a 26.63% increase from the current price of Mex$1,532.71.
What do analysts say about Sanofi?
Sanofi’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Street analysts.
How can I buy shares of Sanofi?
To buy shares of MX:SAN1N, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.